Curanex Pharmaceuticals Inc (NASDAQ: CURX) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CURANEX PHARMACEUTICALS INC

Curanex Pharmaceuticals Inc (NASDAQ: CURX)
Listen to this Section


$0.27
+0.0130 ( +4.98% ) 43.6K

Curanex Pharmaceuticals Inc is engaged in discovering, developing, and commercializing botanical drugs for treating unmet medical needs in patients with inflammatory disease. Its compound, Phyto-N, is in preclinical research for six indications: ulcerative colitis, atopic dermatitis, COVID-19, type 2 diabetes, nonalcoholic fatty liver disease (NAFLD) and gout.

Market Data


Open $0.27
Previous Close $0.26
Volume 43.6K
Market Cap $7.40M
Day Range $0.27 - $0.29
52 Week Range $0.26 - $9.18
Shares Outstanding 28.36M
Change % +4.98%
Net Change ▲ 0.0130
Insider Ownership N/A
Exchange NASDAQ
Sector
IndustryPHARMACEUTICAL PREPARATIONS
IPO Year2025
CountryUnited States
UnderwriterDominari Securities, Revere Securities, Pacific Century Securities, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
3 Insider transactions 1 Sep 02, 2025
3 Insider transactions 1 Sep 02, 2025
3 Insider transactions 1 Sep 02, 2025
8-k 8K-related 14 Aug 27, 2025
8-k 8K-related 15 Aug 26, 2025

Latest News